Microbot Medical Shares Surge Following Key FDA Clearance

Microbot Medical’s stock continues its remarkable upward trajectory, posting a 5.14% gain yesterday to close at $3.48. This marks the third consecutive day of positive momentum for the equity. The longer-term performance is even more striking, with the share price having skyrocketed 235% over the past month and an impressive 300% across the last twelve months.

The recent momentum was further bolstered by a significant financial development on September 15. The company secured access to up to $92.2 million through the exercise of outstanding preferred stock options. An initial tranche of $25.2 million has already been realized, with an additional $4 million expected by mid-October. Management intends to deploy this capital to accelerate the commercial launch of its LIBERTY® system, potentially fund acquisitions, and expand intellectual property rights.... Read more...